Copy to clipboard 
Zebra Medical Vision and DePuy Ireland entered into a global co-development and commercialization agreement to bring artificial intelligence (AI) opportunities to orthopedics, based on imaging data.
Zebra-Med’s AI technology uses algorithms to create three-dimensional models from x-ray images as an affordable alternative to CT scans and MRI imaging for pre-operative surgical planning. It may enable more frequent use of other tools, like patient-specific instruments or robotic assistance, without reliance on traditional MRI or CT-based imaging.
This technology will be introduced as part of DePuy Synthes’ VELYS Digital Surgery solutions for pre-op, operative and post-op patient care. VELYS is planned to pave the way in orthopedics with a platform comprising connected technologies that leverage data insights for patients, surgeons and healthcare systems before, during and after surgery.
“We are thrilled to start this collaboration and have the opportunity to impact and improve orthopaedic procedures and outcomes in areas including the knee, hip, shoulder, trauma and spine care,” said Eyal Gura, Co-Founder and CEO of Zebra Medical Vision. “We share a common vision surrounding the impact we can have on patients’ lives through the use of AI, and we are happy to initiate such a meaningful strategic partnership, leveraging the tools and knowledge we have built around bone health AI in the last five years.”
Zebra Medical is funded in part by Johnson & Johnson Innovation – JJDC, Inc. The company has raised $52 million in funding to date; its offerings are installed in hospitals globally, from Australia to India, Europe to the U.S, and the LATAM region.
